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Background: Avoidant/Restrictive Food Intake Disorder (ARFID) is a “new” diagnosis in the recently published DSM-5,
but there is very little literature on patients with ARFID. Our objectives were to determine the prevalence of ARFID in
children and adolescents undergoing day treatment for an eating disorder, and to compare ARFID patients to other
eating disorder patients in the same cohort.
Methods: A retrospective chart review of 7-17 year olds admitted to a day program for younger patients with eating
disorders between 2008 and 2012 was performed. Patients with ARFID were compared to those with anorexia nervosa,
bulimia nervosa, and other specified feeding or eating disorder/unspecified feeding or eating disorder with respect
to demographics, anthropometrics, clinical symptoms, and psychometric testing, using Chi-square, ANOVA, and
post-hoc analysis.
Results: 39/173 (22.5%) patients met ARFID criteria. The ARFID group was younger than the non-ARFID group
and had a greater proportion of males. Similar degrees of weight loss and malnutrition were found between
groups. Patients with ARFID reported greater fears of vomiting and/or choking and food texture issues than
those with other eating disorders, as well as greater dependency on nutritional supplements at intake. Children’s
Eating Attitudes Test scores were lower for children with than without ARFID. A higher comorbidity of anxiety
disorders, pervasive developmental disorder, and learning disorders, and a lower comorbidity of depression,
were found in those with ARFID.
Conclusions: This study demonstrates that there are significant demographic and clinical characteristics that
differentiate children with ARFID from those with other eating disorders in a day treatment program, and helps
substantiate the recognition of ARFID as a distinct eating disorder diagnosis in the DSM-5.
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Historically, children and adolescents have not been eas-
ily diagnosed with eating disorders (EDs) based on past
versions of the Diagnostic and Statistical Manual of
Mental Disorders (DSM), including the 4th edition. In
fact, over 50% of these patients met criteria for Eating* Correspondence: rornstein@hmc.psu.edu
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ing to missed diagnoses and difficulty obtaining appro-
priate and timely treatment [1-3]. With the preparations
for publication of the 5th edition of the DSM (DSM-5),
the Eating Disorders Work Group was assigned the tasks
of improving clinical utility of the diagnostic categories
and reducing the frequency of EDNOS. One of the im-
peratives was to recognize new disorders and eliminate
others by exploring the clinical profiles of patients who
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developmental, or life-span, approach to all disorders.
Feeding Disorder of Infancy or Early Childhood, a
diagnosis in the DSM-IV, delineated a persistent eating
dysfunction leading to weight loss or failure to gain
weight, with the requirement that patients be less than
six years of age. This was a non-specific diagnostic cat-
egory that was rarely used in practice and for which
there was insufficient literature [4]. A great number of
patients are over six years old at the time of initial ED
evaluation, even if some have had symptoms from an
early age, and have been necessarily given the diagnosis
EDNOS in the past. Feeding Disorder of Infancy or Early
Childhood also excluded those children with abnormal
eating patterns or nutritionally deficient or limited diets,
but who were growing normally secondary to sufficient
caloric intake, possibly due to the use of nutritional supple-
ments. The inability of DSM-IV to capture such patients
was significant, as they often presented with considerable
impairment, both physically and functionally [5].
Clinicians and researchers have long recognized specific
types of EDs that fall under the umbrella of EDNOS. The
Great Ormond Street (GOS) classification system cap-
tured a way to describe these types of patients, and was
often utilized by clinicians for descriptive purposes. These
criteria were actually found to have a higher inter-rater
reliability for younger patients than the DSM-IV [1].
The GOS categories include: Food Avoidant Emotional
Disorder (FAED), Selective Eating, and Functional Dys-
phagia, as well as Anorexia Nervosa (AN) and Bulimia
Nervosa (BN).
FAED was first described as a combination of inad-
equate food intake and emotional disturbance; these
young people knew that they were underweight and
wanted to be heavier, but found this difficult to achieve [6].
The GOS system further clarified this group, and differen-
tiated their presentation by the absence of weight and
shape concerns in the presence of significant food restric-
tion. Somatic complaints were frequent as well as more
general psychopathology, e.g. generalized anxiety [4,5].
Selective eating, also known as “picky eating”, is a
common problem of childhood, with anywhere between
13 to 22% of children between 3 and 11 years of age
being reported to be picky eaters at any given time [7].
While young children are typically thought to “grow out
of” their pickiness, studies have shown that between 18
and 40% of the rigidity concerning food persists into
adolescence [8-10]. Patients with selective eating are
usually not underweight, as they take in adequate calo-
ries from preferred foods, but their diets may be lack-
ing in micronutrients. Some selective eaters have
sensory concerns related to the taste, smell, color, or
texture of foods, which may limit their intake to such a
narrow range of acceptable foods that weight loss, orfailure to gain appropriate weight, may occur. Studies
have shown a higher prevalence of boys with selective
eating, as well as a high degree of co-morbid anxiety
[11,12].
Functional dysphagia is a fear of swallowing or an
inability to eat or swallow food, especially solid or lumpy
foods. There is generally a fear of gagging, choking, or
vomiting, often subsequent to actual traumatic episodes
or witnessed episodes. Sometimes an illogical connection
in the child’s mind leads to development of the phobia.
Some children present with food refusal specifically
out of fears of vomiting, contamination, poisoning, or
defecation as well. Many cases of acute food refusal due
to specific fears present clinically malnourished and ill,
as they often lose weight rapidly. They can easily be mis-
taken with AN on initial presentation due to the severity
of the restriction; however, they are not concerned with
weight or shape [4,5].
The DSM-5 has subsumed and expanded Feeding Dis-
order of Infancy or Early Childhood to capture a greater
number of patients who present with avoidant or re-
strictive eating, but are clearly different from those with
AN in that there are no disturbed cognitions about weight
and/or shape, or a wish to lose weight. It has been renamed
Avoidant/Restrictive Food Intake Disorder (ARFID) and
includes those types of patients recognized in the GOS sys-
tem. Patients with ARFID may present with clinically sig-
nificant restrictive eating leading to weight loss or lack of
weight gain, nutritional deficiencies, reliance on tube feed-
ing or oral nutritional supplements and/or disturbances in
psychosocial functioning (see Table 1) [13]. Additionally,
they may exhibit similar physical signs and symptoms as
patients with AN due to semi-starvation.
Very little has been published on patients with ARFID.
Recently, a large multicenter study of children and ado-
lescents presenting as new patients to adolescent medi-
cine ED programs, revealed a 14% prevalence of ARFID,
with unique clinical characteristics, including younger
age and a greater number of males [14,15]. An 11-year
retrospective chart review of adolescent ED patients in
Canada reported a 5% prevalence of ARFID [16]. These
patients were compared to a matched sample of AN pa-
tients, and demonstrated a younger age at presentation,
and a higher likelihood of being male. There were spe-
cific behaviors and symptoms in the ARFID group, in-
cluding food avoidance, decreased appetite, abdominal
pain, and emetophobia. Both of these studies included
all new patients presenting for initial assessments to
tertiary care ED programs.
Due to the dearth of literature on ARFID, we sought
to determine the prevalence and clinical characteristics
of ARFID in young patients admitted to a day treatment
program for EDs, and to compare patients with ARFID
to those with AN, BN, and Other Specified Feeding or
Table 1 Diagnostic Criteria for Avoidant/Restrictive Food Intake Disorder
WHAT IS ARFID? WHAT ARFID IS NOT
● A problem with eating or feeding (e.g. seeming disinterest in food or
eating; repulsion to certain foods based on their sensory qualities;
fears about aversive effects of eating) leading to recurrent inability to
take in adequate nutrition and/or energy coupled with one (or more)
of the following:
● The eating problems are not due to body image disturbance, and anorexia
nervosa or bulimia nervosa cannot be diagnosed instead.
○ Major nutritional deficiency. ● Feeding or eating problems are not the result of scarcity of food or a
culturally endorsed tradition.
○ Substantial weight loss (or lack of weight gain). ● The disordered eating is not due to a concomitant medical problem or
another psychiatric disorder, so that if the medical or psychiatric disorder is
treated, the eating problems resolves.
○ Reliance on nasogastric or gastric tube feeding or oral nutrition
supplements.
○ Impaired psychosocial function.
Adapted from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, American Psychiatric Association, 2013.
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(OSFED/UFED) in the same cohort.Methods
Participants
A retrospective chart review was conducted on 177 pa-
tients admitted to a day program for children and ado-
lescents with EDs between August 4th, 2008 and May
1st, 2012. This program treats female and male patients,
ages 7 to 17 years, with EDs and co-morbid psychopath-
ology. The majority of patients in the program have re-
strictive EDs, based mostly on the younger average age.
However, patients with purging disorders are treated as
well. While we treat some patients with sensory features
related to food, who may or may not also have an autism
spectrum disorder diagnosis, it is important to clarify
that patients with longstanding feeding issues and aut-
ism are not typically admitted to our program, and are
usually managed in the Feeding Disorders Program at
our institution.
Initial ED and co-morbid psychiatric diagnoses were
made upon admission to the program based on a com-
prehensive diagnostic psychiatric evaluation, by both a
trained child and adolescent psychiatrist and either an
experienced clinical psychologist or a licensed social
worker/clinical psychiatric specialist, using DSM-IV-TR
criteria. Some of the co-morbid diagnoses were based on
history conveyed by the parent to the health care provider.
DSM-5 ED diagnoses were determined retrospectively and
agreed upon together through careful discussion by two of
the psychiatric specialists and an adolescent medicine
physician, all of whom were personally involved with the
cases, using a checklist based on the proposed DSM-5
diagnostic criteria, which were almost identical to the
published criteria. Therefore, these diagnoses were not
made in a blinded fashion.Of the 177 eligible subjects, a total of four participants
were excluded from the study. Two were excluded for
having medical conditions that were retrospectively
determined to fully account for their disordered eating
behaviors. Two subjects were excluded for having
Binge Eating Disorder and composed too small a distinct
group for data analysis.
Measures
Demographics, historical and clinical features
Data collected at intake included age, gender, and ethni-
city. Historical information included past history of ED
and/or other mental health treatment, other medical disor-
ders and consultations by other medical specialists, pres-
ence of weight loss, percentage of body weight lost, length
of illness, use of nutritional supplements, presence of pur-
ging behaviors, excessive exercise, history of food allergies,
fears of choking and/or vomiting, and sensory issues re-
lated to food. This information was gathered from the ini-
tial evaluations by the adolescent medicine physician, the
psychiatrist, and the psychologist or clinical social worker.
Anthropometrics
Weight and height were measured by trained staff at
initial presentation. Gowned weights were obtained on a
hospital-grade SECA digital scale and recorded to the
nearest tenth of a kg. Heights were measured in bare
feet using a fixed stadiometer with a right angle head-
piece and recorded to the nearest tenth of a cm. BMI
was calculated using the standard formula (kg/m2) and
the % Median Body Weight (%MBW) was determined
based on the 50th percentile BMI-for-age.
Psychometric measures
The Children’s Eating Attitudes Test (ChEAT) [17] The
ChEAT is a 26-item scale assessing attitudes and behaviors
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as young as 8 years old, adapted from the original
EAT-26 [18]. A score of ≥ 20 is considered clinically
significant relative to the normative population. The
three subscales reflecting varying types of eating path-
ology include: Dieting, Bulimia/Food Preoccupation,
and Oral Control [18].
Children’s Depression Inventory (CDI) [19]. The CDI is
a 27-item self-report inventory for assessing depression
in children between the ages of 7 and 17 years. The
measure yields a Total score (M = 50; SD = 10) and five
factors: Negative Mood, Interpersonal Problems, Ineffect-
iveness, Anhedonia, and Negative Self-Esteem (M= 10;
SD = 3).
Revised Children’s Manifest Anxiety Scale (RCMAS)
[20]. The RCMAS is a 37 item self-report instrument de-
signed to measure anxiety for children and adolescents
ages 6 to 17 years. The measure yields a Total Anxiety
score based upon 28 items, with 9 items comprising the
Lie Scale which is designed to detect responses that are
socially desirable. The Total Anxiety Score is expressed as
a T-score (M = 50, SD = 10) and there are three factor-
based subscales, expressed as scaled scores (M = 10,
SD = 3): Physiological Anxiety, Worry/Oversensitivity,
and Social Concerns/Concentration.
The Child Behavior Checklist (CBCL) [21]. The CBCL
provides three global measurements which are expressed
as a T- score (M = 50; SD = 10) including Total Score;
Internalizing; and Externalizing Scales. In addition, the
measure includes 14 Syndrome Scores which reflect
clusters of psychiatric symptoms. These scales are also
expressed as T-scores (M = 50; SD = 10) and include
the following scales: Anxious/Depressed, Withdrawn/
Depressed, Somatic Complaints, Social Problems, Thought
Problems, Attention Problems, Rule-Breaking Problems,
Aggressive Behavior, Affective Problems, Anxiety Problems,
Somatic Complaints, ADHD Problems, Oppositional Defi-
ant Problems, and Conduct Problems. It is completed by
parents and/or other caregivers.Statistical analysis
Analysis included descriptive statistics, chi-square, ana-
lysis of variance (ANOVA), and Pearson’s correlation.
Bonferroni correction was used to adjust for Type I error,
with thresholds set at p < 0.01 for patient characteristics,
p < 0.007 for ED symptoms and features, and p < 0.008 for
psychiatric co-morbidities. Post-hoc testing to examine
between-groups effects was performed with the Hochberg
GT2 test. Data were entered and analyzed using SPSS
(version17.0, SPSS Inc., Chicago, Illinois).
This study was approved by the Institutional Review
Board of the Penn State Hershey Medical Center/College
of Medicine.Results
Demographics and anthropometrics
Using the proposed DSM-5 criteria, 39 (22.5%) patients
met criteria for ARFID, 93 (53.8%) for AN, 20 (11.6%)
for BN, and 21 (12.1%) for OSFED/UFED. Notably, all
patients diagnosed with ARFID carried a DSM-IV diag-
nosis of EDNOS. None were diagnosed with DSM-IV
Feeding Disorder of Infancy or Early Childhood, as all
were over six years old at intake. Of the 173 participants
included, 92% were female with a mean age of 13.5 years
(SD = 2.03) (range 7.2 -16.9 years). The cohort was pre-
dominantly Caucasian (95%), reflecting the ethnic/racial
makeup of the geographic area. There was no significant
difference in duration of illness between those patients
with ARFID and the other ED groups.
Patients with ARFID were found to be younger than
those with other EDs (11.1 years, SD = 1.7 vs. 14.2 years,
SD = 1.5; p < 0.0001) and to have a greater percentage of
males (20.5% vs 4.5%; p = 0.008). Of the patients who
had lost weight as part of their ED, those with AN lost a
greater percentage of their premorbid weight than the
other ED groups, including those with ARFID (Table 2).
There was a significant difference found in %MBW
between those with ARFID and BN, but not between
ARFID and AN, or OSFED/UFED (Table 2). While the
degree of malnutrition was similar to that of patients
with AN, those with ARFID were found to have a
greater dependence on nutritional supplements, fears of
vomiting and/or choking, and texture/sensory issues
pertaining to food (all p < 0.0001).
Psychometric assessment and psychiatric co-morbidities
Patients with ARFID were less likely to report typical ED
symptoms, e.g. purging behaviors and excessive exercise,
during intake interview (all p <0.0001). In addition, they
had significantly lower total scores on the ChEAT (14.86,
SD = 2.10) than those of the remaining patients overall
(27.51, SD = 17.28) (p < 0.0001) (Figure 1). Post-hoc ana-
lysis revealed significant differences among patients with
ARFID and all other groups for the total ChEAT score.
While patients with ARFID also had significantly lower
scores on both the Dieting and Bulimia Nervosa/Food
Preoccupation subscales (p < 0.0001), there was no signifi-
cant difference between groups on the Oral Control sub-
scale. An interesting finding on chart review was that
while patients with ARFID did not have true body image
distortion, as seen in AN, 21% exhibited body preoccupa-
tion with somatic concerns. For example, some children
were fixated on fears of physical illness due to issues re-
lated to shape/weight, e.g. high cholesterol and/or obesity
leading to heart disease, either because of personal experi-
ences with relatives or information in their school curricu-
lum. Others who were chronically underweight due to
their feeding and eating disturbance had suffered teasing
Table 2 Clinical characteristics of patients by eating disorder diagnosis
ARFID AN BN OSFED/UFED p-value
(N = 39) (N = 93) (N = 20) (N = 21)
Patient Characteristics (mean or %)
Age (years) (SD) 11.1 (1.7)* 14.0 (1.5) 14.9 (1.1) 14.2 (1.7) <0.0001
% MBW (SD) 87.1 (13.0) 82.6 (9.2) 108.1 (19.5)* 93.2 (6.8) <0.0001
% Body Weight Lost (SD) 10.5 (8.4) 18.5 (10.2)* 6.4 (6.5) 14.8 (12.2) <0.0001
Length of illness (months) (SD) 9.8 (13.2) 8.6 (7.9) 15.9 (11.9) 9.8 (4.9) N.S.
% Female 79.5 95.7 100 90.5 0.008
% Male 20.5* 4.3 0 9.5
Symptoms & Features (%)
Enteral Supplement Use 46* 20 0 0 <0.0001
Purge-vomit 0 6 95* 38 <0.0001
Excessive exercise 15* 68 65 52 <0.0001
Food allergy 20 5 10 5 N.S.
Fear of choking or vomiting 44* 1 0 0 <0.0001
Sensory issues 26* 1 0 0 <0.0001
Recent medical specialist consult 46 19 20 33 N.S.
Psychiatric comorbidities (%)
Mood disorder 33* 48 80 76 <0.0001
Anxiety disorder 72* 37 25 14 <0.0001
Autism Spectrum Disorder 13* 0 0 0 0.001
Attention Deficit Disorder 4* 0 1 1 N.S.
Learning Disorder 10* 2 2 0 <0.0001
Cognitive impairment 26* 2 10 0 <0.0001
*Significant finding on post-hoc analysis using Hochberg GT2 test.
AN = Anorexia Nervosa ARFID = Avoidant/Restrictive Food Intake Disorder.
BN = Bulimia Nervosa OSFED/UFED = Other Specified Feeding or Eating Disorder/Unspecified Feeding or Eating Disorder % MBW =% Median Body Weight.
Figure 1 Total and subscale ChEAT scores by DSM-5 Diagnosis. ChEAT = Children’s Eating Attitudes Test. All differences between groups
significant at p < 0.0001 except Oral Control = N.S.
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have led to body image concerns, although of a different
nature than typically seen in AN and BN.
There was a significantly higher comorbidity of anxiety
disorders in patients with ARFID (72%) than the other
ED groups (31%), as determined by clinician diagnosis
(p < 0.0001). Furthermore, this was supported by paren-
tal report on the CBCL (p =0.005). However, there were
no significant differences between groups on the total
RCMAS score. Autism spectrum disorder (p = 0.001),
learning disorders (p < 0.0001), and cognitive impair-
ment (p < 0.0001) were also seen more frequently in the
patients with ARFID, based on past history reported at
initial assessment (Table 2). On the CBCL, children with
ARFID had significantly more social problems (p = 0.001)
and attention problems (p < 0.0001) than those with AN.
There was a lower comorbidity of depression diagnosed in
children with ARFID (23%) than the other EDs (57%)
(p < 0.0001), and total CDI scores were lower in this group
as well (54.4 vs. 60.0, p = 0.05). Additionally, children with
ARFID were found to have significantly lower scores on
the CDI subscales Negative Mood (p =0.02) and Negative
Self Esteem (p < 0.0001). There were no significant differ-
ences between the groups on the Interpersonal Problems,
Ineffectiveness, or Anhedonia subscales, however.
A smaller percentage of children with ARFID (35%)
sought outpatient psychotherapy before coming to the
program, compared to patients in the other ED groups
(AN = 60.22%, EDNOS = 75%, BN= 80%; p = 0.002). How-
ever, there were no differences in the past history of
higher levels of psychiatric care, e.g. inpatient, residential,
or day treatment. In contrast, more children with ARFID
(46.2%) had seen other medical specialists for consultation
(e.g. gastroenterology, endocrinology) before coming to
program than those with other EDs (26.1%), although this
did not reach statistical significance with the Bonferroni
correction (p = 0.02).
Discussion
This study adds to the literature on ARFID by compar-
ing a cohort of children and adolescents undergoing day
treatment for EDs, including patients with this “new”
diagnosis. Notably, almost a quarter of our patients were
diagnosed with ARFID, which illustrates the significant
prevalence of this disorder amongst children and adoles-
cents requiring an intensive level of ED treatment in a
tertiary care setting. This was a higher prevalence than
that found in the multicenter studies [14,15], which
might be accounted for by the fact that our patients
were encountered over four years in a day treatment set-
ting, as opposed to all ED patients presenting for initial
evaluation over a one-year period. The prevalence rate
was in even starker contrast to the 11-year retrospective
review from Canada, where the prevalence was onlyfound to be 5% [16]. There is no mention of age range
in that study, only that the patients were adolescent
ED patients assessed in a pediatric tertiary care hospital
program. Our study included children and adolescents
between 7 and 17 years, which may have been a slightly
lower range than the Canadian study; this might also
justify the higher prevalence of ARFID found in our
cohort. Another possible explanation for the discrepancy
in prevalence rates across studies is that younger pa-
tients with atypical EDs, like ARFID, may be increasingly
referred to adolescent medicine ED programs in more
recent years, as there has been greater recognition of
these presentations as true EDs. The Canadian study
reviewed records starting in 2000 and it would be inter-
esting to know whether the prevalence increased annu-
ally over the 11 years. In our experience, referrals from
primary care providers tend to generate more referrals
once they are successfully managed. Lastly, the higher
prevalence in our cohort may reflect the fact that many
children and adolescents with ARFID present acutely
and significantly malnourished, requiring a higher level
of care, such as day treatment.
Similar to the multicenter and Canadian studies [15,16],
our results demonstrate that there are significant demo-
graphic and diagnostic characteristics that differentiate
children with ARFID from those with other EDs. First,
while female patients remain the majority, there was a
higher preponderance of male patients in the ARFID
group than in the other ED groups. Children and adoles-
cents with ARFID were more likely to present at a youn-
ger age with significant weight loss or failure to gain
appropriate weight, were more dependent on oral or
enteral nutritional supplementation, and had significantly
more fears of choking and/or vomiting, and texture and/
or sensitivity issues regarding food. These findings are
consistent with those in studies of early-onset EDs
[2,22,23], as well as in the recent multicenter study [15],
and many are relevant and important features in making
the diagnosis of ARFID [24].
Based on DSM-5 criteria, a patient cannot have body
image distortion and be diagnosed with ARFID. How-
ever, our data revealed that 21% of patients diagnosed
with ARFID had body preoccupation with somatic
concerns. It is important to reiterate that none of the
patients with ARFID had been diagnosed with AN using
DSM-IV criteria, which underscores the absence of true
body image distortion. During evaluation of a young
patient with possible ARFID versus AN, it is critical to
probe about body concerns that need to be distinguished
from body image distortion. For example, if a patient
has worries about becoming fat, this may have some-
thing to do with events in the family’s medical history,
e.g. an overweight parent or grandparent with a recent
myocardial infarction or diabetes diagnosis. Children
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may make illogical associations based on their cognitive
developmental stage. This knowledge may then trigger
restrictive eating behaviors. Thorough history-taking can
often elicit this information.
As has been documented in other studies of patients
with acute food avoidance without weight/shape con-
cerns [2,15,22,25,26], there were no significant differ-
ences in our study between % MBW in patients with
ARFID and AN; however, patients with AN lost a signifi-
cantly greater percentage of their premorbid body weight.
This may be explained by the fact that our patients with
ARFID, notably those with the acute food refusal seen in
functional dysphagia, may have presented sooner after the
onset of illness than those with AN. The data may not
fully bear this out due to the heterogeneity of the ARFID
category (e.g. more chronic selective eaters vs more
acute food refusal), which might balance out the length
of illness data. Furthermore, young patients may present
relatively early in the course of their illness, based on
their age alone.
Based on both clinician and parental report, patients
with ARFID had significantly more anxiety and less de-
pression than patients with other EDs, which is similar
to findings in the large multicenter study on ARFID
[15]. However, our study is the first of patients with
ARFID to use standardized measures obtained from par-
ents to aid in evaluation. There were no self-reported
significant differences found between children with ARFID
and those with other EDs on the RCMAS or any of its
subscales, which could be due to the generally high comor-
bidity of anxiety symptoms in EDs. Alternatively, younger
patients (those more likely to be diagnosed with ARFID)
may have had a harder time filling out the questionnaire
than older subjects, perhaps in understanding the ques-
tions or acknowledging symptoms of anxiety, due to cog-
nitive developmental stage. It is important to clarify that
ARFID is not simply a type of anxiety disorder, as the
severity of the eating disturbance exceeds that which
might be seen in an anxiety disorder and necessitates
further clinical attention (see Table 1) [13].
Other than the use of outpatient psychotherapy, there
were no significant differences between the groups in
terms of prior mental health treatment, including hospi-
talizations for EDs or other mental health issues, admis-
sions to day treatment programs, intensive outpatient
programs, or residential treatment facilities. It should be
taken into consideration, however, that ours is a young,
relatively treatment-naïve population, and that the rate
of past mental health admissions would be very different
when looking at an older population of patients. Add-
itionally, children with ARFID may be more likely seen
as medically ill initially, and the early referrals may tend
to gravitate toward the medical as opposed to mentalhealth arena, as a trend in our data revealed, although it
was not significant.
There were several strengths to this study, including
the large sample size and the use of both clinical and
standardized psychometric measures for patient assess-
ment. Additionally, the use of multiple informants (pa-
tients, parents, and clinicians) adds to the validity of the
findings. Furthermore, experienced clinicians completed
all assessments and the adolescent medicine physician
involved in deciding on the retrospective DSM-5 diagno-
ses was integrally involved in the efforts leading up to
the inclusion of ARFID in the DSM-5. As ARFID is still
a relatively “new” diagnosis, there are no formalized
assessment tools available yet. However, instruments will
likely be developed, capturing the clinical features and
diagnostic criteria which will help standardize diagnosis.
There are some available resources to help guide the
clinician in evaluation [24,27].
However, there are several limitations that deserve
mention. The retrospective nature of this study, and the
fact that diagnoses were made on DSM-5 criteria that
had not yet been formalized by the time of its comple-
tion, need to be taken into consideration. However,
as previously mentioned, the published DSM-5 criteria
were essentially the same as the proposed criteria used
for this study. Careful discussion amongst experienced
clinicians very familiar with all of the cases was under-
taken to decide upon the appropriate DSM-5 diagnosis
for each patient; this did not allow for direct assessment
of inter-rater reliability. The absence of blinding of the
clinicians may have introduced bias to the outcome of
the study, possibly leading to a higher prevalence of
ARFID than previously seen in other studies. Lastly, our
patients were undergoing day treatment, which im-
plies a certain severity of illness, and may limit the
generalizability to patients in other settings, or non-
clinical populations. Despite these limitations, this study
provides support for ARFID as a separate diagnostic
category.
Conclusions
This is the first study to examine patients with the diag-
nosis of ARFID in a cohort of patients undergoing day
treatment and adds to the limited literature available on
this new diagnosis. The inclusion of psychometric mea-
sures from both patients and parents has not been docu-
mented to date. Children and adolescents with ARFID
are clearly distinct from those with other EDs and can
now be identified and labeled more specifically and ac-
curately. Ideally, this will enable more timely recognition
and access to care. The degree of both physical and psy-
chosocial dysfunction with which these patients present
indicates the need for prompt and appropriate treat-
ment. The relatively high prevalence of patients with
Nicely et al. Journal of Eating Disorders 2014, 2:21 Page 8 of 8
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for an intensive level of care for many of these children
and adolescents, depending on their initial presentation.
Future research on ARFID, with respect to course, prog-
nosis and treatment is warranted.
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